Akorn agreed to buy Hi-Tech Pharmacal for $640 million in cash, a deal that allows the niche pharmaceutical company to diversify its retail offerings.
via WSJ.com: US Business http://online.wsj.com/article/SB10001424127887323407104579038833015573534.html?mod=pls_whats_news_us_business_f
via WSJ.com: US Business http://online.wsj.com/article/SB10001424127887323407104579038833015573534.html?mod=pls_whats_news_us_business_f
Nessun commento:
Posta un commento